Bovie Medical

Document Sample
Bovie Medical Powered By Docstoc
					   This presentation may contain some forward looking
    statements, particularly regarding operational
    prospects in 2008 and beyond, which involve a
    number of risks and uncertainties that could cause
    actual results to differ materially. These risks are
    listed from time to time in the Company’s SEC filings.

   Surgical instruments in the OR that are
    related to electrosurgery are called by
    the name “BOVIE.”
   Branding the “Bovie” name within the
    medical community
   Over 32 million surgical procedures in
  Bovie Medical
               MEG Line

  ICON                        Icon GS
Generators                     Plasma


 Tissue                        Canaday
Resection                     Accessories

High & Low Temperature Cauteries
   Targeted towards the
    Gastroenterology market.
   Over $150 million market
    including accessories growing 7-
    9% per year
   13,000 operating centers
   Icon platform provides the basis
    to develop customized
    generators for other specialties
    (ex. Oncology $200 million).
MEG line of instruments
MEG/Polaris™ Instruments
    The only product that can compete in three
    markets and address all areas of minimally
    invasive surgeries:
   Arthroscopy Instrument Market $200 million
    Laparoscopy Instrument Market $300 million
   Vessel Sealing Market $500 million
    Arthroscopy Instrument
   Market research indicates little to no
    innovation from top five companies in
    this space over the past 15 years.
   The only modular arthroscopy
    instrument available.
   Can dramatically reduce cost to the
    end user.
   The only arthroscopy instrument with
    a flushing port for cleaning.
   One tip design can replace multiple
    Laparoscopy Instrument
   Handle accepts inserts from 2mm
    to 12mm
   Cancelable ratchet feature can be
    activated either left or right
   Ergonomic handle reduces fatigue
    and creates more leverage.
   Modular design can significantly
    reduce cost
   Metallic handle is electrically
    isolated to increase instrument life.
              Vessel Sealing Instrument
   Only modular designed laparoscopic VS instrument
   Handle can accommodate both “open” and laparoscopic
    instrument tips.
   “Seal and Cut” design.
   Can be used with existing vessel sealing generators or
    user can gain enhanced benefits with Bovie generator.
   Significantly reduces costs.
   Largest (total market size $500 million) and fastest
    growing (10-15%) segment with highest margins.
•360 Rotation of cartridge
•Electrode quick attachment-
•Can be controlled by three
    Jaw trigger
    Coagulation + sealing
    Powered blade trigger
Handle & Bovie VS generator
   •Cartridge recognition and initial
   •Automatic bipolar cut upon
   blade advancement
   •Modulated vessel sealing
   automatic cycles
   •Minimal charring and adhesion
 Suitable for a variety of endoscopic Bipolar AND
        Monopolar or Inert applications like

            Vessel Sealing
              Endo GYN
         Thoracic Endoscopy
and many other open surgery adaptations
               Tissue Resection Device

   Delivers RF current & sterile saline for resection,
    hemostatic sealing and coagulation
   Lowers blood loss, procedure times and cost savings
    for hospitals
   Liver, pancreatic, kidney tumor removal
   Orthopedic and laparoscopic surgeries
   Worldwide market size in 2009 approx. $500 million
         ICON GS Plasma System
   J-Plasma is formed by holding a sharp
    conductive point at High Voltage and High
    Frequency, over which an Inert Gas, such as
    Helium, flows.
         ICON GS Plasma System
   Produces a stable thin focused beam of
    ionized helium gas
   Provides minimal invasiveness and
   No conductive currents during surgery
   One working electrode
     Canady Technology Agreements
   Worldwide distribution and manufacturing agreement
    for Canady’s plasma related devices and accessories.
   Canady Technology will assist in the clinical
    development of Bovie’s J-Plasma technology.
   Canady Technology was the first to demonstrate the
    utilization of tissue coagulation by argon plasma
    coagulation via flexible endoscopes.
Bovie Medical Financials
Amex Symbol: BVX
 Fiscal year 2007 revenues rose to a
  record $28.78 million.
 Net income for fiscal 2007 was

  $2,400,591 or $.14 per diluted EPS.
 17,600,000 diluted shares outstanding.

 10% insider ownership.
 Contact Information
        Bovie Medical, Inc.
Suite 207, 734 Walt Whitman Road
        Melville, NY 11747

Buttonwood Advisory Group, Inc.
     15705 Framingham Lane
      Huntersville, NC 28078